Oxycodone HCL-Acetaminophen Tablets

Award NoticeAwarded

This federal contract opportunity has been awarded to on September 29, 2022.

Award Information

This solicitation resulted in an award to for approximately $7,299,520 on September 29, 2022. Similar contracts are typically issued by DEPT OF DEFENSE under 32541 (Pharmaceutical and Medicine Manufacturing).

Award Number
SPE2D222D0150
Award Amount
$7,299,520
Award Date
September 29, 2022

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical and Medicine Manufacturing

Contract Details

Notice ID
SPE2D221R0114
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Wednesday, September 2, 2026
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

SPE2D2-22-D-0150 P00009 to invoke Option Year 4 SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for pharmaceutical and medicine manufacturing in PHILADELPHIA, PA.